Carlsmed (CARL) Change in Accured Expenses (2024 - 2026)

Carlsmed has reported Change in Accured Expenses for 3 years, with the latest figure at -$74000.0 in Q1 2026.

• For the quarter ending Q1 2026, Change in Accured Expenses rose 93.29% year-over-year to -$74000.0; the trailing twelve-month figure through Mar 2026 stood at $3.5 million (changed N/A YoY), and the FY2025 full-year result was $2.5 million, up 106.13% from the prior year.
• Change in Accured Expenses for Q1 2026 stood at -$74000.0, down from $2.0 million in the prior quarter.
• The five-year high for Change in Accured Expenses was $2.0 million in Q4 2025, with the low at -$1.1 million in Q1 2025.
• Historically, Change in Accured Expenses has averaged $591857.1 across 3 years, with a median of $608000.0 in 2025.
• Annual changes were most pronounced in 2025 — Change in Accured Expenses soared 41.93% — and 2026, when it soared 93.29%.
• Carlsmed's Change in Accured Expenses stood at $1.4 million in 2024, then soared by 41.93% to $2.0 million in 2025, then tumbled by 103.78% to -$74000.0 in 2026.
• The last three Change in Accured Expenses figures came in at -$74000.0 (Q1 2026), $2.0 million (Q4 2025), and $608000.0 (Q3 2025), per Business Quant data.